Upregulation of AKR1B10 in chemotherapy-resistant medulloblastoma D341 and colon cancer HT29 cancer cell lines underscore the utility of this enzyme as a biomarker of drug resistance. Here, AKR1B10 is linked to colonic neoplasm.